Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cigalah is a premier healthcare distributor and service provider headquartered in Saudi Arabia, acting as a vital link between global life science companies and the Middle Eastern market. Established in 1987, the company manages an extensive portfolio that includes pharmaceuticals, medical equipment, laboratory supplies, and consumer health products. Cigalah serves as the exclusive distributor for numerous multinational corporations, including Bayer, Novartis, and Roche, ensuring the delivery of critical medicines across the Kingdom. The group has also expanded its footprint into healthcare manufacturing and clinical services through specialized subsidiaries. With a robust logistics infrastructure and deep regulatory expertise, Cigalah is a dominant player in the Saudi Arabian healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cigalah.